Biegel & Waller’s Immunomedics Inc IMMU Stock Holding History

Biegel & Waller’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$172K	Hold	13,000	–	–	0.1%	69
2019 Q2	$180K	Hold	13,000	–	–	0.09%	75
2019 Q1	$250K	Hold	13,000	–	–	0.13%	65
2018 Q4	$186K	Hold	13,000	–	–	0.11%	69
2018 Q3	$271K	Hold	13,000	–	–	0.16%	59
2018 Q2	$308K	Hold	13,000	–	–	0.19%	49
2018 Q1	$190K	Hold	13,000	–	–	0.12%	54
2017 Q4	$210K	Hold	13,000	–	–	0.12%	53
2017 Q3	$182K	Hold	13,000	–	–	0.11%	51
2017 Q2	$115K	Hold	13,000	–	–	0.07%	55
2017 Q1	$84K	Hold	13,000	–	–	0.06%	48
2016 Q4	$56K	Buy	+13,000	New	+$38.5K	0.04%	53

Other funds holding IMMU

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

RP Management New York $139M AUM 37.98% 1-Year Est. Return